35
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Drug consumption facilities: an update since 2000

, , , &
Pages 227-233 | Published online: 12 Jul 2009

References

  • Dolan K, Kimber J, Fry C, Fitzgerald J, MacDonald D, Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Aus- tralia. Drug Alcohol Rev 2000; 19: 337–46.
  • Schneider W, Sto¨ ver H. Guidelines for the operation and use of consumption rooms. Materialien no. 4. Mu¨ nster: Akzept e.V & Carl von Ossietzky Universita¨t Oldenburg; May 2000.
  • Stoever H. Consumption rooms—a middle ground between health and public order concerns. J Drug Issues 2002; 22(Spring): 597–697.
  • Chitwood D, McCoy C. Incardi J et al. HIV seropositivity of needles for shooting galleries in South Florida. Am J Public Health 1990; 80: 150–152.
  • Carlson R. Shooting galleries, dope houses, and injection doctors: examining the social ecology of HIV risk behaviors among drug injectors in Dayton, Ohio. Hum Org 2000; 59: 325–333.
  • Parliament of New South Wales. Report on the establish- ment or trial of safe injecting rooms. Joint Select Committee into Safe Injecting Rooms. Sydney: Parliament of New South Wales, 1998.
  • Farrell M, Hall W. Swiss Heroin trials: testing alternative approaches. Br Med J 1998;317:639.
  • Kerr T, Palepu A. Safe injection facilities in Canada: Is it time? Can Med Assoc J 2001; 165: 439–7.
  • Broadhead RS, Kerr TH, Grund J, Altice FL. Safer injection facilities in North America: their place in public policy and health initiatives. J Drug Issues 2002; 32: 329–55.
  • Skretting A. Public injection rooms, a help to heroin addicts? Nord Alk Narkotikatidskr [English supplement] 2002; 19: 33–49.
  • Balotta D. Recent developments in the ELDD: new action plan on drugs in Norway. Drugnet Europe 2002;38:5.
  • Fischer B, Rehm J, Kim G, Robins A. Safer Injection Facilities (SIFs) for Injection Drug Users (IDUs) in Canada. Can J Public Health 2002; 93: 336–8.
  • Campbell W, el-Guebaly N. Safer injection facilities for injection drug users: the debate continues [letters]. Can Med Assoc J 2002;166:421.
  • Vlaming S. Safer injection facilities for injection drug users: the debate continues [letters]. Can Med Assoc J 2002;166:419.
  • Latowsky M. Safer injection facilities for injection drug users: the debate continues [letters]. Can Med Assoc J 2002; 166: 419–20.
  • Brock G, Gurekas V. Safer injection facilities for injection drug users: the debate continues [letters]. Can Med Assoc J 2002;166(4):420 – 1.
  • Elliot R, Malkin I, Gold J. Establishing safe injection facilities in Canada: legal and ethical issues. Can HIV/AIDS Policy Law Rev 2002; 6: 7–9.
  • Special Committee on Non-Medical Use of Drugs. Final Report of the Special Committee on Non-Medical Use of Drugs. Ottawa: Parliament of Canada; 2002. URL: http:// www.parl.gc.ca/InfoComDoc/37/2/SNUD/Studies/Reports/ snudrp01/16-ch5-e.htm#18 [accessed 13/2/03].
  • Programme DSaCS. Application for an exemption under Section 56 of the Controlled Drugs and Substances Act for a Scientific Purpose for a Pilot Supervised Injection Site Research Project Interim Guidance Document. Ottawa: Health Canada, 2002.
  • Basu A. Canada: Safe-injection sites to get federal OK. Winnipeg Free Press 2002;10 November.
  • Kerr T. Inching closer to safe injection sites? Living + (British Columbia Persons with AIDS Society), 2002.
  • Crosbie J. Minister review proposal for heroin addicts. Irish Times 2000;5 September.
  • Committee. The government’s drug policy: is it working? London: Stationary Office, 2002.
  • Malinowski A. The vein in Spain: viability of safe injecting rooms. Druglink 2002; 17: 20–22.
  • Za´bransk T, Radimeck J, Mravc´ık V et al. Vrocn´ı zpra´va o stavu ve vecech drog 2001 [Annual Report on Drug Situation 2001—Czech Republic]. Prague/Lisbon: Na´rodn´ı monitorovac´ı stredisko pro drogy a drogove´ za´vislosti and EMCDDA, 2002.
  • Hedrich D. Experts discuss supervised consumption facil- ities. Drugnet Europe 2002;38:3.
  • Hedrich D. European Report on Drug Consumption Rooms. Lisbon: European Monitoring Centre Drugs and Drug Addiction (EMCDDA); In press.
  • International Narcotics Control Board. Report of the International Narcotics Control Board for 2001. Vienna: United Nations, 2002.
  • International Narcotics Control Board. Report of the International Narcotics Control Board for 1999. New York: United Nations, 2000.
  • Board INC. Report of the International Narcotics Control Board. Vienna: United Nations, 2001.
  • Hagan H. Supervised injection rooms—prospects and limitations. Int J Drug Policy 2002; 13: 449–51.
  • Wierling M. Fixerstuben, Druckra¨ume, Konsumra¨ume: Brennpunkte akzeptanzorientierter Drogenarbeit. Mu¨ nster: INDRO e.V., 2002.
  • Malkin I. Establishing supervised injecting facilities: a responsible way to help minimise harm. Melbourne Univ Law Rev 2001;25:680.
  • Wood E, Kerr T, Spittal P et al. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. J Acq Immune Def Syndromes 2003; 32: 3–8.
  • Kelly C, Conigrave K. The Sydney medically supervised injecting centre: a controversial public health measure. Aust NZ J Public Health 2002; 26: 552–4.
  • Kimber J, van Beek I. Consumption rooms: the Australian experience. Akzeptanz 2003; 10: 54–8.
  • International Harm Reduction Association. Programme and abstract book: 11th International Conference on the Reduction of Drug Related Harm. Jersey, United Kingdom, 2000.
  • International Harm Reduction Association. Programme and abstract book: 12th International Conference on the Reduction of Drug Related Harm. New Dehli, India, 2001.
  • International Harm Reduction Association. Book of ab- stracts: 13th International Conference on the Reduction of Drug Related Harm. Ljubljana, Slovenia, 2002.
  • Biesma S, Meijer G, Bieleman B. Opgevangen in het centrum: Evauatie opvangen adviescentrum Apeldoorn. Groningen-Rotterdam: INTRAVAL, 2000.
  • Graff I, Linssen L, Wolf J. Gebruiksruimten in Nederland. Passage 2001; 10: 86–95.
  • Linssen L, de Jong W, Wolf J. Gebruiksruimten: Een systematisch overzicht van de voorziening en de effecten ervan. Utrecht: Trimbos-Instituut, ontwikkelcentrum Social Verslavingsbeleid, 2000.
  • Linssen L, Graff I, Wolf J. Gebruiksruimeten in beeld: Handrieking bij de organisatie enrichtung. Utrecht: Trim- bos Institut, 2002.
  • Meijer G, de Jong A, Koeter M, Bieleman B. Gebruik van de straat: Evaluatie gebruiksruimte binnenstad-Zuid Gro- ningen. Groningen-Rotterdam: INTRAVAL, 2001.
  • Baumga¨rtner T. Welche Auswirkungen haben die gea¨nder- ten Drob-Inn-GR-o¨ ffnungszeiten auf das Nutzungsverhal- ten der BesucherInnen dieser und der dezentralen Enrichtungen? Statistische Auswertungen der Pra¨- und Post-Samstags-Schließungs-Befragungen unter GR-Nutzer- Innen in Hamburg. Hamburg: Institut fu¨ r Interdisziplina¨re Sucht- und Drogenforschung (ISD), 2000.
  • Beho¨ rde fu¨ r Arbeit GuSH-RDuS. Drogenkonsumra¨ume Evaluation 1999/2000. Hamburg: Beho¨ rde fu¨ r Arbeit, Gesundheit und Soziales Hamburg—Referat Drogen und Sucht, 2001.
  • Gessenharter W. Mediatorenverfahren ‘‘Weitere Gesund- heitsra¨ume in St. Georg? Wunschbarkeit, Zweckma¨ßigkeit, Notwendigkeit’’ Abschlußbericht des Mediators. Hamburg: Senat der Freien und Hansestadt Hamburg, 1999.
  • Happel HV. Konsumra¨ume: Eine effective Maßnahme zur Schadensminimierung bei DrogenbraucherInnen und Bu¨ r- gerInnen. Frankfurt: Fachhochschule Frankfurt/M., 1999.
  • Sto¨ ver H. Konsumra¨ume: Zwischenbilanz und Anforder- ungen an Weiterentwicklung und Qualita¨tsicherung. In: Bo¨ llinger L, Sto¨ ver H, editors. Drogenpraxis, Drogenrecht, Drogenpolitik. Frankfurt am Main: Fachhochschulverlag, 2002: 174–89.
  • Happel V, Steinmetz J. Ueberdosierungen im Konsum- raum: Ergebnisse und Erfahrungen nach fu¨ nfja¨hriger Begleitung des gro¨ ssten Frankfurter Konsumraums. In: e.V A, ed. Gesellschaft mit Drogen—Akzeptanz im Wandel. Berlin: VWB, 2001: 189–95.
  • Benninghoff F, Geense R, Dubois-Arber F. Resultate der Studie ‘‘Klienten niederschwelliger Anlaufstellen in der Schweiz: Basel (Gassenzimmer I, II, und K&A Eskamed)’’ Geneve (BIPS), Bienne (Drop-In/Cardinal): Lausanne Institut Universiteaire de Medicine Sociale e Preventive, 2001.
  • Eastus C. Die Entwicklung von Gesundheitsra¨umen in der Schweiz. Akzeptanz 2000; 1: 10–12.
  • Zurhold H. Drogenkonsumra¨ume im Spannungsfeld zwischen gesundheitspolitischen und ordnungspolitischen Wirkungserwartungen. Akzeptanz 2001;2.
  • MSIC Evaluation. Eighteen-month process evaluation report on the medically supervised injecting centre. Sydney: University of New South Wales, 2002.
  • Gerlach R, Schneider W. Injecting Room at INDRO, Mu¨ nster, Germany: some key information and experi- ences—revised and updated internet version. Mu¨ nster: INDRO e.V., 2002.
  • Ronco C, Spuhler G, Coda P, Schopfer R. Evaluation der Gassenzimmer I, II und III in Basel. Sozial und Praventiv- medizin 1996; 41:S58– 68.
  • Poschadel S, Ho¨ ger R, Schnitzler J, Schreckenberg D. Evaluation der Arbeit der Drogenkonsumra¨ume in der Bundesrepublik Deutschland: Bochum: Zentrum fu¨ r ange- wandte Psychologie, Umwelt-und Sozialforschung (ZEUS), 2002.
  • Jacob J, Rottman J, Sto¨ ver H. Entstehung und Praxis eines Gesundheitsraumangebotes fu¨ r Drogenkonsumierende. Ab- schlußbericht der einja¨hrigen Evaluation des ‘drop-in Fixpunkt’, Hannover. Oldenburg: Bibliotheks -und Infor- mationssystem der Universita¨t Oldenburg, 1999.
  • Biesma S, Bieleman B. Keetje Tippel gebruikt. Evaluatie van gebruiksruimte de Buren bij Keetje Tippel te Rotter- dam. Groningen-Rotterdam: INTERVAL, 1998.
  • Biesma S, Bieleman B. Ruimet om te gebruiken: Evaluatie gebruiksruimte Spanjaardstraat Rotterdam. Groningen- Rotterdam: INTRAVAL, 1998.
  • Biesma S, Bieleman B. De Daeke in gebruik. Evaluatie Opvang en Adviescentrum en gebruiksruimte De Daike in Venlo. Groningen-Rotterdam: INTRAVAL, 1998.
  • Geense R. Evaluation of the Federal measures to reduce the problems related to drug use. To have or to have not: that’s the question. A qualitative study on four low threshold needle exchange service for drug users in Switzerland. [Masters of Public Health]. Lausanne: University Institute of Social and Preventative Medicine, 1997.
  • Kemmesies UE. The open drug scene and the safe injection room offers in Frankfurt am Main 1995. Frankfurt: Stadt Frankfurt/Dezernat Frauen und Gesundheit, Drogenreferat, 1999.
  • Bundesministerium fu¨ r Gesundheit und Soziale Sicherung, editor. Evaluation der Arbeit von Drogenkonsumra¨umen in der Bundesrepublik Deutschland. Baden-Baden: Nomos, 2003.
  • MSIC Evaluation. Evaluation Protocol for the trial a Medically Supervised Injecting Centre in Kings Cross. Sydney: University of New South Wales, 2001.
  • Fry C. Injecting drug user attitudes towards rules for supervised injecting rooms: implications for uptake. Int J Drug Policy 2002;13:471 – 6.
  • Homann B, Paul B, Thiel G, Warns M. Drug consumption patterns and the need of drug consumption rooms in the open drug scene of Hamburg [abstract]. Sucht 2000; 46: 129–36.
  • van Beek I, Gilmour S. Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney. Aust NZ J Public Health 2000; 24: 540–2.
  • Spittal P, Craib K, Wood E et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Can Med Assoc J 2002; 166: 894–9.
  • Miller C, Johnston C, Spittal P et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of injecting drug users. Hepatology 2002;36.
  • MSIC Evaluation. Twelve-month process evaluation report on the medically supervised injecting centre. Sydney: University of New South Wales, 2002 May.
  • Gerlach R, Schneider W. Consumption and injecting room (CIR) at INDRO, Mu¨ nster, Germany: Annual Report 2002 [English version]. Mu¨ nster: INDRO e.V., 2003.
  • Kimber J, Dolan K, Wodak A. International survey of supervised injecting centres (1999 – 2000). NDARC Tech- nical Report 126. Sydney: University of New South Wales, 2001.
  • Grund J-P. Drug use as a social ritual—functionality, symbolism and determinants of self-regulation. Rotterdam: University of Rotterdam, 1993.
  • Higgs P, Maher L, Jordens J, Dunlop A, Sargent P. Harm reduction and drug users of Vietnamese ethnicity. Drug Alcohol Rev 2001; 20: 239–45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.